BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gulei D, Mehterov N, Ling H, Stanta G, Braicu C, Berindan-neagoe I. The “good-cop bad-cop” TGF-beta role in breast cancer modulated by non-coding RNAs. Biochimica et Biophysica Acta (BBA) - General Subjects 2017;1861:1661-75. [DOI: 10.1016/j.bbagen.2017.04.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Grewal RK, Chetty M, Abayomi EA, Tomuleasa C, Fromm JR. Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma. Cytometry B Clin Cytom 2019;96:116-27. [PMID: 30350336 DOI: 10.1002/cyto.b.21724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
2 Zhu L, Liu Z, Dong R, Wang X, Zhang M, Guo X, Yu N, Zeng A. MicroRNA-3662 targets ZEB1 and attenuates the invasion of the highly aggressive melanoma cell line A375. Cancer Manag Res 2019;11:5845-56. [PMID: 31388313 DOI: 10.2147/CMAR.S200540] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
3 Ciocan-Cȃrtiţă CA, Jurj A, Raduly L, Cojocneanu R, Moldovan A, Pileczki V, Pop LA, Budişan L, Braicu C, Korban SS, Berindan-Neagoe I. New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin. Mol Cell Biochem 2020;475:285-99. [PMID: 32888160 DOI: 10.1007/s11010-020-03881-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, Ionescu C, Berindan-Neagoe I. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers (Basel) 2019;11:E1618. [PMID: 31652660 DOI: 10.3390/cancers11101618] [Cited by in Crossref: 134] [Cited by in F6Publishing: 125] [Article Influence: 44.7] [Reference Citation Analysis]
5 Jacobs Catane L, Moshel O, Smith Y, Davidson B, Reich R. Splice-Variant Knock-Out of TGFβ Receptors Perturbates the Proteome of Ovarian Carcinoma Cells. Int J Mol Sci 2021;22:12647. [PMID: 34884451 DOI: 10.3390/ijms222312647] [Reference Citation Analysis]
6 Velloso FJ, Bianco AF, Farias JO, Torres NE, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG. The crossroads of breast cancer progression: insights into the modulation of major signaling pathways. Onco Targets Ther 2017;10:5491-524. [PMID: 29200866 DOI: 10.2147/OTT.S142154] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
7 Abolghasemi M, Tehrani SS, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, Jadidi-Niaragh F, Yousefi M, Kafil HS, Bastami M, Edalati M, Eyvazi S, Naghizadeh M, Targhazeh N, Mihanfar A, Yousefi B, Safa A, Majidinia M, Rameshknia V. Critical roles of long noncoding RNAs in breast cancer. J Cell Physiol 2020;235:5059-71. [PMID: 31951025 DOI: 10.1002/jcp.29442] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
8 Catana CS, Crișan CA, Opre D, Berindan-Neagoe I. Implications of Long Non-Coding RNAs in Age-Altered Proteostasis. Aging Dis 2020;11:692-704. [PMID: 32489713 DOI: 10.14336/AD.2019.0814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Xie H, Yu H, Tian S, Yang X, Wang X, Wang H, Guo Z. MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation. Oncotarget 2018;9:15252-65. [PMID: 29632641 DOI: 10.18632/oncotarget.24165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
10 Braicu C, Gulei D, Raduly L, Harangus A, Rusu A, Berindan-Neagoe I. Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms. Mol Aspects Med 2019;70:90-105. [PMID: 31703947 DOI: 10.1016/j.mam.2019.10.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gulei D, Irimie AI, Cojocneanu-petric R, Schultze JL, Berindan-neagoe I. Exosomes—Small Players, Big Sound. Bioconjugate Chem 2018;29:635-48. [DOI: 10.1021/acs.bioconjchem.8b00003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
12 Gulei D, Mehterov N, Nabavi SM, Atanasov AG, Berindan-neagoe I. Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibition. Biotechnology Advances 2018;36:1779-99. [DOI: 10.1016/j.biotechadv.2017.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
13 Sandiford OA, Moore CA, Du J, Boulad M, Gergues M, Eltouky H, Rameshwar P. Human Aging and Cancer: Role of miRNA in Tumor Microenvironment. Adv Exp Med Biol. 2018;1056:137-152. [PMID: 29754179 DOI: 10.1007/978-3-319-74470-4_9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
14 Dudea-Simon M, Mihu D, Irimie A, Cojocneanu R, Korban SS, Oprean R, Braicu C, Berindan-Neagoe I. Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis. Int J Mol Sci 2020;21:E7323. [PMID: 33023042 DOI: 10.3390/ijms21197323] [Reference Citation Analysis]
15 Fischer C, Reiner C, Schmidmaier G, Doll J, Child C, Grützner PA, Biglari B, Boxriker S, Moghaddam A. Safety study: is there a pathologic IGF-1, PDGF and TGF-β cytokine expression caused by adjunct BMP-7 in tibial and femoral non-union therapy? Ther Clin Risk Manag 2018;14:691-7. [PMID: 29713178 DOI: 10.2147/TCRM.S160064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Braicu C, Buiga R, Cojocneanu R, Buse M, Raduly L, Pop LA, Chira S, Budisan L, Jurj A, Ciocan C, Magdo L, Irimie A, Dobrota F, Petrut B, Berindan-Neagoe I. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression. J Exp Clin Cancer Res 2019;38:433. [PMID: 31665050 DOI: 10.1186/s13046-019-1406-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
17 Zhang F, Xu Y, Ye W, Jiang J, Wu C. Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2. Biosci Rep 2020;40:BSR20200825. [PMID: 32667627 DOI: 10.1042/BSR20200825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Gulei D, Petrut B, Tigu AB, Onaciu A, Fischer-Fodor E, Atanasov AG, Ionescu C, Berindan-Neagoe I. Exosomes at a glance - common nominators for cancer hallmarks and novel diagnosis tools. Crit Rev Biochem Mol Biol 2018;53:564-77. [PMID: 30247075 DOI: 10.1080/10409238.2018.1508276] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
19 Gulei D, Magdo L, Jurj A, Raduly L, Cojocneanu-Petric R, Moldovan A, Moldovan C, Florea A, Pasca S, Pop LA, Moisoiu V, Budisan L, Pop-Bica C, Ciocan C, Buiga R, Muresan MS, Stiufiuc R, Ionescu C, Berindan-Neagoe I. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression. Cell Death Dis 2018;9:66. [PMID: 29352232 DOI: 10.1038/s41419-017-0102-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 10.5] [Reference Citation Analysis]
20 Gulei D, Raduly L, Broseghini E, Ferracin M, Berindan-Neagoe I. The extensive role of miR-155 in malignant and non-malignant diseases. Mol Aspects Med 2019;70:33-56. [PMID: 31558293 DOI: 10.1016/j.mam.2019.09.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
21 Liu WB, Feng QJ, Li GS, Shen P, Li YN, Zhang FJ. Long non-coding RNA HOTAIRM1-1 silencing in cartilage tissue induces osteoarthritis through microRNA-125b. Exp Ther Med 2021;22:933. [PMID: 34306202 DOI: 10.3892/etm.2021.10365] [Reference Citation Analysis]
22 Expósito-Villén A, E Aránega A, Franco D. Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition. Noncoding RNA 2018;4:E14. [PMID: 29843425 DOI: 10.3390/ncrna4020014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
23 Chen W, Qin Y, Liu S. Cytokines, breast cancer stem cells (BCSCs) and chemoresistance. Clin Transl Med 2018;7:27. [PMID: 30175384 DOI: 10.1186/s40169-018-0205-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
24 Klinge CM, Piell KM, Tooley CS, Rouchka EC. HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells. Sci Rep 2019;9:9430. [PMID: 31263129 DOI: 10.1038/s41598-019-45636-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
25 Suzuki HI. MicroRNA Control of TGF-β Signaling. Int J Mol Sci 2018;19:E1901. [PMID: 29958433 DOI: 10.3390/ijms19071901] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 12.5] [Reference Citation Analysis]
26 Petri BJ, Klinge CM. Regulation of breast cancer metastasis signaling by miRNAs. Cancer Metastasis Rev 2020;39:837-86. [PMID: 32577859 DOI: 10.1007/s10555-020-09905-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
27 Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I. miR-181a/b therapy in lung cancer: reality or myth? Mol Oncol 2019;13:9-25. [PMID: 30548184 DOI: 10.1002/1878-0261.12420] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
28 Huang W, Yang Y, Wu J, Niu Y, Yao Y, Zhang J, Huang X, Liang S, Chen R, Chen S, Guo L. Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling. Cell Death Differ 2020;27:1709-27. [PMID: 31728016 DOI: 10.1038/s41418-019-0455-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
29 Gulei D, Berindan-Neagoe I. Combined Therapy in Cancer: The Non-coding Approach. Mol Ther Nucleic Acids 2018;12:787-92. [PMID: 30141411 DOI: 10.1016/j.omtn.2018.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Li X, Ma C, Zhang L, Li N, Zhang X, He J, He R, Shao M, Wang J, Kang L, Han C. LncRNAAC132217.4, a KLF8-regulated long non-coding RNA, facilitates oral squamous cell carcinoma metastasis by upregulating IGF2 expression. Cancer Letters 2017;407:45-56. [DOI: 10.1016/j.canlet.2017.08.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
31 Irimie AI, Ciocan C, Gulei D, Mehterov N, Atanasov AG, Dudea D, Berindan-Neagoe I. Current Insights into Oral Cancer Epigenetics. Int J Mol Sci 2018;19:E670. [PMID: 29495520 DOI: 10.3390/ijms19030670] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]